The United States is globally recognized as the undisputed number one country in biotechnology innovation, research, and commercialization. Bolstered by massive venture capital ecosystems, elite research universities, world-class medical centers, and robust intellectual property protections, major US hubs like Boston and San Francisco lead the world in developing breakthrough therapeutics, gene editing, and cell therapies.